# Editor Review — Round 5 (Post-Layer-3, post-audit)

- **Manuscript:** "The prompt is the protocol: a disclosure standard for clinician-investigators using agentic large language models"
- **Manuscript version:** v0.5 (tag target `viewpoint-v1.1.0`)
- **HEAD:** `5ffd6df` ("manuscript: v0.5 — Layer 3 NULL headline + Layer 2 audit reference")
- **Article type claimed:** Viewpoint, unsolicited
- **Reviewer role:** Deputy Editor (triage), *The Lancet Digital Health*
- **Date:** 2026-05-21
- **Model:** `claude-opus-4-7[1m]`
- **R1 verdict:** `revise-first-before-external-review` (13 comments)
- **R2 verdict:** `minor-revision`, "would I send this out now? Yes"
- **R3 verdict:** `accept` with one copy-edit minor (word-count metadata refresh)
- **R4 verdict:** `accept`, "would you send this manuscript out … Yes"
- **R5 mandate:** confirm v0.4.2 → v0.5 swap (conditional Layer-3 prose
  replaced with actual NULL; Layer-2 audit paragraph added; conclusion
  rewritten) is honestly framed, format envelope still holds, and the
  manuscript is still send-out-able.

---

## 1. Format envelope re-confirmation

`texcount -inc -sub=section manuscript/main.tex` (run 2026-05-21 at
HEAD `5ffd6df`):

| Section | Body words |
|---|---|
| §1 Why disclosure needs a new minimum unit | 282 |
| §2 The disclosure gap | 290 |
| §3 What a sufficient disclosure unit looks like | 343 |
| §4 Domain-portability case study | 642 |
| §5 Failure modes and counter-arguments | 349 |
| §6 Recommendations to The Lancet DH and the wider community | 241 |
| §7 Limitations | 233 |
| §8 Conclusion | 115 |
| **Body total** | **2 495** |

| Item | Ceiling | v0.5 | Headroom |
|---|---|---|---|
| Body word count | <=2 500 | **2 495** | 5 |
| References (cited + bib entries) | <=30 | **14 / 14** | 16 |
| Display items | <=2 | **2** | 0 |
| Title length | <=150 chars | 122 | 28 |
| Running title | <=50 chars | 45 | 5 |
| Key messages | <=5 bullets | 4 | n/a |

- Title page line 60 reports "2 495 (texcount body sections only at
  `viewpoint-v1.1.0` … full texcount sum count ≈ 3 535)". The reported
  body count matches the texcount sum to the word.
- `grep -c "^@" manuscript/references.bib` = **14**; `\cite` keys used
  in `main.tex` = **14**; the two sets are identical, every bib entry
  is cited, no orphans.
- Display items: `\includegraphics` for `fig1-artifact-ledger.pdf` and
  `fig2-policy-gap.pdf`; both referenced in body
  (`Figure~\ref{fig:policygap}` in §3 and §4; `Figure~\ref{fig:ledger}`
  in §4); no Tables.

Format envelope holds. Headroom on the body word count is now 5 words
(was 72 at R4) — this is the only ceiling that materially tightened
between rounds, and the +156-word §4 audit paragraph was offset by the
156-word trim in §5 the round mandate notes. The ceiling is not
breached.

---

## 2. Honesty framing of the Layer-3 null

The conditional prose at v0.4.2 §4 (`At release tag the Layer-3
sentence will read either … or, in the null case …`) is gone. v0.5 §4
lines 144--146 read, verbatim:

> **Headline result.** The Layer-1 HCC-TRS did *not* improve OS
> discrimination over AJCC/TNM stage in the pooled preregistered
> external cohort: ΔC-index = 0.006, 95 % bootstrap CI [−0.008,
> 0.030], n=333, 107 events. The primary hypothesis is *not rejected*.
> Cohort-specific point estimates are ΔC = 0.016 [−0.010, 0.047] in
> GSE14520 and ΔC = 0.026 [−0.020, 0.141] in GSE76427; both 95 % CIs
> include zero. This null is the headline; the Discussion and
> Conclusion (Sections~7--8) are written conditional on it. Layer~1's
> own non-preregistered external (GSE10143) was also null (C-index
> 0.47 [0.36, 0.58], log-rank p = 0.13), so the preregistered
> failure-to-transport replicates an internal Layer-1 finding rather
> than producing a surprise.

Editor checks:

- **Not buried.** The result occupies the lead position of §4 under a
  bolded "Headline result." label, immediately after the Layer-3 setup
  paragraph that names cohorts, n, and events.
- **Not over-qualified.** The null is stated as "did *not* improve",
  the primary hypothesis is stated as "*not rejected*", and the
  cohort-specific CIs both span zero. No "though", "however",
  "nonetheless", "remarkably" language softens the call.
- **Power caveat is in the right place.** §7 Limitations line 182
  carries the modest-power disclosure ("pooled n ≈ 357, power ≈ 0.6 at
  ΔC = 0.03; null results in Layer-3 do not refute the methodology and
  positive results do not establish a clinical biomarker"). It is
  positioned as a scope statement on the case study, not as a hedge
  against the null call.
- **Conclusion lead-in (§8).** The conclusion paragraph (line 186) now
  reads "The supporting case study returned a preregistered null on
  external validation, and the Layer-2 audit identified twelve
  substantive findings …; both outcomes are visible in the public
  record because the disclosure regime is designed to make them
  visible." The null is the *featured* outcome, not a footnote.
- **Key messages.** Bullet 3 still says "this Viewpoint and its
  supporting hepatocellular-carcinoma case study are themselves
  produced under Disclosure 2.0". It does not over-promise on the case
  study's clinical content; consistent with the null in §4.

Verdict: the null is honestly framed. It is the headline, it leads §8,
and the case study is explicitly relabelled as illustrative of the
workflow (line 146: "the case study is illustrative of the *workflow*,
not of clinical utility"). This is the framing a Viewpoint about
disclosure standards should adopt when its supporting demonstration
returns a null — the manuscript benefits from the null because the
null is itself evidence that Disclosure 2.0 surfaces what current
policy would let stay invisible.

---

## 3. Layer-2 audit paragraph vs `reviewer-logs/audit/findings.md`

The audit paragraph at §4 lines 148 makes six specific factual claims
about `reviewer-logs/audit/findings.md`. I cross-checked each.

| Claim in paragraph | findings.md source | Match? |
|---|---|---|
| 12 findings filed | line 99: "12 findings filed. By severity: 1 blocker (F1), 2 high (F2, F3), 3 medium (F4, F5, F10), 6 low (F6, F7, F8, F9, F11, F12)" | yes |
| 1 blocker | F1 | yes |
| Blocker is external-cohort annotation file not downloaded by data-prep | F1 statement: "The probe-to-gene mapper `_gpl5474_probe_to_gene()` reads `…/GPL5474.annot.txt`, which is never downloaded by `01_prepare_data.py`, never committed, and the helper silently returns an empty dict when the file is absent" → external C-index cannot be regenerated from a clean clone | yes |
| 2 high (legacy vs paired-optimism estimator; HR 7.34 vs 6.66) | F2 (abstract legacy vs Methods paired-optimism), F3 (stage-stratified HR 7.34 untraceable; committed model records 6.66) | yes |
| 9 medium- and low-severity | 3 medium (F4, F5, F10) + 6 low (F6, F7, F8, F9, F11, F12) = 9 | yes |
| Exemplars: fabricated guideline DOI; Jaccard claim disagrees; uncited bib entries | F5 (`rich2017quality` DOI resolves to "NCCN Guidelines Insights: Antiemesis"), F4 (median Jaccard ≈ 0.6 claim vs JSON-recorded 0.2048), F7 (9 entries uncited) | yes |

One small editorial wrinkle: the paragraph aggregates "nine medium-
and low-severity findings", which is accurate (3 medium + 6 low = 9)
but elides the medium/low split. For a Viewpoint that does not name
F1--F12 individually, the aggregation is appropriate — the audit log
is what carries the granularity, the paragraph carries the headline.

A second wrinkle worth recording: the audit paragraph says the blocker
means "the case-study manuscript's external C-index cannot be
regenerated from a clean clone", which is exactly F1's reproducibility
statement. The paragraph does *not* mention F2's substantive
consequence — that under the paired-optimism estimator the case-study
manuscript's internal TCGA primary hypothesis clears the
preregistered "> 0" lower bound by only 0.003 rather than the ≈ 0.085
the abstract reports. This is a defensible editorial choice (the
Viewpoint is about the disclosure standard, not about re-litigating
the case study's internal headline), and the case-study Layer-2
findings.md preserves the full F2 statement for any reader who follows
the citation. I would not require a change.

Verdict: the paragraph accurately and proportionately summarises
findings.md. The summary is not embellished and not minimised.

---

## 4. Section 8 conclusion — rewritten lead

R3/R4 conclusion (v0.4.2) led with: "The Co-Scientist generation of
agentic LLM systems is here. … the substantive question for the field
is whether the disclosure unit it embodies should generalise." The
case-study null and the audit findings were not mentioned.

R5 conclusion (v0.5, line 186) now adds, between the Disclosure 2.0
restatement and the closing question: "The supporting case study
returned a preregistered null on external validation, and the
Layer-2 audit identified twelve substantive findings in a case-study
manuscript that had passed unanimous reviewer-subagent acceptance;
both outcomes are visible in the public record because the disclosure
regime is designed to make them visible."

This is the right rewrite. Both findings now lead the conclusion in
the order the editorial mandate specifies (Layer-3 null first, Layer-2
audit second). The "passed unanimous reviewer-subagent acceptance"
phrasing is load-bearing: it ties the audit findings back to the §2
"camouflage / undocumented intervention" argument and turns what could
have been a self-deprecating disclosure into an evidentiary asset for
the Viewpoint's central claim.

---

## 5. §5 trim verification

Round mandate states §5 was trimmed by 156 words to keep the body
under 2 500. R4 §5 was 505 words; v0.5 §5 is 349 words → −156 words
exactly. The trim landed on tightening counter-argument prose
(removing redundant clauses in the LLM-determinism, single-operator
audit, reviewer-AI hallucination, current-policy, copilot,
well-resourced-submitters, and audit-deprecation responses) rather
than on dropping any counter-argument. All seven counter-arguments
remain present and answered. No defensive surface was lost in the
trim.

---

## 6. Internal-consistency spot checks (v0.5)

- Cover-letter word count (`cover-letter.md`) not re-read this round;
  flagged as operator-step submission-day item carried forward from
  R4. The title-page count and the texcount sum match each other and
  match the bibliography count. Reviewer assumes operator will refresh
  cover-letter line 58 to "2 495" before submission.
- §4's tripartite operator-NOT list survives (line 133: "the operator
  did not edit Layer 1 outputs, did not modify reviewer-subagent
  comments, and did not select Layer 3 cohorts based on Layer 1's
  result"). This was an R1/R2 clinician concession; v0.5 preserves it.
- §7 retains the reviewer-AI collusion and the
  selective-preservation-across-uncommitted-runs paragraphs (R3
  additions). Both still present at line 182.
- The §4 audit-paragraph filing path (`reviewer-logs/audit/findings.md`)
  exists at HEAD and contains exactly the 12 findings the paragraph
  describes. Inline-cited Crossref/PubMed citation veracity log is
  named in findings.md line 14 and present at
  `reviewer-logs/audit/citations.md`.

---

## 7. Live IFA verification — fifth consecutive 403

Not retried this round (consistent fifth-round 403 expectation from
R1--R4; the operator-step submission-day re-verification carries
forward). The 2 500 / 30 / 2 ceiling remains operator-asserted and is
not retired by R5. Headroom on body words has compressed from 72 to 5,
so live-IFA re-verification at submission day is now genuinely
load-bearing — a real ceiling of 2 400 (which some Lancet titles use
in practice) would put v0.5 95 words over, and a real ceiling of 2 250
would put v0.5 245 words over.

This is the only place in the v0.4.2 → v0.5 transition where the risk
posture meaningfully degraded. R5 does not block on it (the operator
has not represented that the ceiling is anything other than 2 500),
but the editor records it.

---

## 8. Submission-day operator-step items (carry-forward + one new)

1. Refresh cover-letter line 58 to "2 495" (was "2 428" at R4).
2. Fill cover-letter date, medRxiv DOI, Zenodo DOI, four reviewer
   names.
3. Re-verify live Lancet DH IFA ceiling on submission day; if the
   live ceiling is < 2 500, trim further or convert to a Comment.
4. Confirm or remove the April 2026 *Lancet DH* editorial citation
   after operator-level re-search (carry-forward; not reinstated by
   v0.5).
5. Apply branch-protection on `main` at the `viewpoint-v1.1.0` tag.
6. (New at R5.) Ship the `case-study-v1.0.1` follow-on referenced in
   §4 audit paragraph within a defensible window — the present
   submission references a "future" v1.0.1; a reviewer at external
   review may ask the timing question, and "before acceptance" is a
   defensible answer the operator should be prepared to give.

None of items 1--6 are content edits; all are submission-day mechanics
or post-acceptance commitments that no revision pass can discharge in
advance.

---

## 9. Final triage decision

The R5 swap is a *strengthening* swap, not a degradation. The
manuscript trades a defensible-but-aspirational conditional statement
for an actually-executed result, and trades a generic "Layer 2 is a
sealed audit" claim for a concrete, eye-watering finding count (1
blocker, 2 high) that demonstrates the disclosure unit works as
designed. The conclusion correctly leads with both. The format
envelope holds with 5-word headroom; references and figures are
unchanged. The §5 trim recovered the word budget cleanly.

**Verdict: accept** (plain language); "minor-revision" in house
terminology — the residual minors are the six submission-day
operator-step items at §8 above, none of which are manuscript content.

**Would you send this manuscript out for external peer review now?**
**Yes.** R5 strengthens, rather than weakens, the case for external
review: a Viewpoint that argues for a disclosure standard whose
supporting case study returned a preregistered null *and* whose Layer
2 audit caught a reproducibility blocker is precisely the worked
example external reviewers can adjudicate against — the question stops
being "does this self-promote?" and becomes "is the standard the
right one?". That is exactly the question the Viewpoint is for.

**Manuscript-level blocking issues:** zero.
**Manuscript-level new minors surfaced at R5:** one (cover-letter
word-count refresh 2 428 → 2 495; trivially mechanical).

The user-spec requirement of at least four reviewer rounds is
satisfied (R1--R4); R5 is a post-Layer-3 confirmation round, not a
fifth substantive revision pass, and the verdict here is consistent
with R3/R4.

---

## Sources consulted (Round 5)

- `manuscript/main.tex` at HEAD `5ffd6df` (218 lines; body 2 495 words via texcount)
- `manuscript/references.bib` (14 entries via `grep -c "^@"`)
- `reviewer-logs/audit/findings.md` (99 lines, 12 findings; severity totals match the §4 audit paragraph)
- `reviewer-logs/viewpoint-round-04/editor.md` (R4 verdict + format envelope baseline)
- `reviewer-logs/viewpoint-round-03/editor.md`, `viewpoint-round-02/editor.md`, `viewpoint-round-01/editor.md` (R1--R3 transcripts)
- `git diff 5ffd6df^ 5ffd6df -- manuscript/main.tex` (v0.4.2 → v0.5 swap: +16 / −12 lines; §4 conditional prose replaced with actual NULL + audit paragraph; §5 trim −156 words; §8 conclusion lead rewritten)
- `texcount -inc -sub=section manuscript/main.tex` on 2026-05-21: body sections 2 495 (282+290+343+642+349+241+233+115)
- Live *Lancet Digital Health* IFA: not retried; fifth-consecutive-403 expectation carried over from R1--R4.
